SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Synchrony Financial (New York Stock Exchange:SYF)

US · Delayed Price · Currency is USD
72.05+0.12 (+0.17%)
 
Market Cap23.44B+1.2%
Revenue (ttm)18.96B-2.4%
Net Income3.52B+7.0%
EPS9.76+18.4%
Shares Out325.37M
PE Ratio7.28
Forward PE6.93
Dividend$1.24(1.73%)
Ex-Dividend DateAug 5, 2026
Volume181,211
Open71.27
Previous Close71.93
Day's Range71.27 - 72.53
52-Week Range63.08 - 88.77
Beta1.34
AnalystsBuy
Price Target88.18(+22.39%)
Earnings DateOct 20, 2026
+0.19% (1D)
No price history available.
Insider Score
––Not scored
SYF Insider Score

Insiders here have filed 31 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About SYF

Synchrony Financial, along with its various subsidiaries, functions as a leading provider of consumer financial services across the United States. The company offers a comprehensive range of credit products, encompassing diverse credit card options such as private label, co-branded, and general-purpose cards, alongside commercial credit solutions and consumer installment loans for both short and long durations. Additionally, Synchrony provides consumer banking services, including a variety of deposit products like certificates of deposit, individual retirement accounts, money market accounts, and savings accounts. These are made available to both individual consumers and commercial entities, with deposits also accepted via external securities brokerage firms. Beyond core credit and banking, Synchrony extends debt cancellation programs to its credit card clientele through online, mobile, and direct mail channels. It is also a significant player in specialized financing, offering healthcare payment and funding solutions under its CareCredit, Pets Best, and Walgreens brands. The firm further provides payment and financing options to industries like apparel, specialty retail, outdoor, music, and luxury, as well as point-of-sale consumer financing for audiology products and dental services. Synchrony delivers its credit offerings through collaborative programs established with a broad network of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers. Its deposit products reach customers through various avenues, including digital and print media. The company's services cater to a wide array of sectors, including digital, health and wellness, retail, home, auto, powersports, jewelry, and pet industries, among others. Established in 1932, Synchrony Financial's corporate headquarters are located in Stamford, Connecticut.

Address
777 Long Ridge Road, Stamford, CT, 06902, US
Market Cap
23.44 billion
Employees
20,000
Industrial Classification
Financial - Credit Services
1 Day
-0.17%
5 Days
-0.31%
1 Month
-8.66%
6 Months
-0.22%
1 Year
+1.18%

$SYF stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of SYF by members of U.S. Congress

PoliticianTypeTraded
Alan ArmstrongSenate / RPurchase$1.00K – $15.00KMar 27, 2026
French HillHouse / RSale$15.00K – $50.00KApr 14, 2021
Gilbert CisnerosHouse / DSale$1.00K – $15.00KApr 29, 2020
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KApr 29, 2020
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KApr 28, 2020
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KMar 18, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 18, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 17, 2020

Recently reported changes in SYF holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SYF's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SYF Estimated quarterly lobbying spending

Source: U.S. Senate LDA

SYF Revenue by Segment

$14.89BTotal
SegmentRevenue% of All
Synchrony Segment$5.58B37.50%
Interest and fees on loans$5.38B36.14%
Net charge-offs$1.36B9.16%
Net earnings$885.00M5.94%
Employee costs$516.00M3.47%
Information processing$248.00M1.67%
Professional fees$220.00M1.48%
Interest on cash and debt securities$203.00M1.36%
Other income:$137.00M0.92%
Marketing and business development$137.00M0.92%
Other income$137.00M0.92%
Fraud-related operational losses$78.00M0.52%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New SYF patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SYF from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SYF

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$825.02M
VOOVanguard S&P 500 ETF$688.54M
VOVanguard Morningstar Mid-Cap ETF$561.80M
RDVYFirst Trust Rising Dividend Achievers ETF$474.20M
IVViShares Core S&P 500 ETF$311.41M
SPYState Street SPDR S&P 500 ETF$283.58M

Estimated from each fund’s disclosed top holdings × AUM

SYF Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for SYF is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from SYF’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.